Evidence map›Paper›PMID 33988141›Full record

ArticleActa bio-medica : Atenei Parmensis2021

COVID-19 in transplant recipient children: An Iranian referral hospital-based study.

Golnaz Ghazizadeh Esslami, Setareh Mamishi, Shima Mahmoudi, Amene Navaeian, Maryam Behfar, Amir Ali Hamidieh, Hosein Alimadadi, Yasmine Mahmoudieh

Open access · greenAbstract read
In one paragraph

Article in Acta bio-medica : Atenei Parmensis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Severity of SARS-CoV-2 infection in children with inborn errors of immunity (primary immunodeficiencies): a systematic review.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2023
    Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Golnaz Ghazizadeh EsslamiTehran University of Medical Sciences. gh.esslami@gmail.com.
Setareh Mamishia:1:{s:5:"en_US";s:37:"Tehran University of Medical sciences";}. smamishi@sina.tums.ac.ir.
Shima MahmoudiTehran University of Medical Sciences. sh-mahmoudi@sina.tums.ac.ir.
Amene NavaeianTehran University of Medical Sciences. navaeianamene@gmail.com.
Maryam BehfarTehran University of Medical Sciences. behfarm@alumnus.tums.ac.ir.
Amir Ali HamidiehTehran University of Medical Sciences. aahamidieh@sina.tums.ac.ir.
Hosein AlimadadiTehran University of Medical Sciences. hoseinalimadadi@yahoo.com.
Yasmine Mahmoudieh7- Department of Molecular and Cell Biology, University of California, Berkeley . yasminemahmoudieh@berkeley.edu.
Tehran University of Medical Sciences · IRUniversity of California, Berkeley · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To our knowledge, there is still very limited information on the severity, mortality, laboratory, and radiologic findings of COVID-19 infection in transplant patients, particularly children. In this study, we report and analyze 7 transplant recipients with laboratory-confirmed COVID-19 infection. The median age was 7.5 years (IQR: 31month-10 years), and 71% of the patients were male. All cases presented with a fever. The median duration of fever before admission was 2 days (IQR:1-8 days). Five patients (71%) experienced cough and dyspnea. Lymphocytopenia (Median of 0.6 (IQR: 0.14-2.0× 10⁹ cells per L) and thrombocytopenia (Median of 65 (IQR: 49-201× 10⁹ cells per L) were the most common CBC findings (both seen in 5 out of the 7 patients. Among 4 of the patients who underwent CT scans, 2 had ground glass opacity and consolidations. The mean number of lobe involvement in our patients was 3(0-5), and 75% of the cases showed bilateral lung involvement in the imaging. In 4 patients (51%) the disease course manifested severely, and 2 patients are now deceased (28.6%). In conclusion, immunocompromised pediatric subgroups may experience higher rates of disease severity and mortality in comparison with the immunocompetent pediatric population.

Indexed as

COVID-19ChildHospitalsHumansIranMaleReferral and ConsultationSARS-CoV-2Transplant Recipients

Identifiers

PMID33988141
PMCPMC8182621
OpenAlexW3160665713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.